Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-13,953
Closed -$2.05M 118
2026
Q1
$2.05M Buy
13,953
+322
+2% +$52.3K 0.58% 52
2025
Q4
$2.66M Sell
13,631
-25
-0.2% -$5.95K 0.75% 37
2025
Q3
$3.84M Sell
13,656
-2,848
-17% -$725K 1.09% 18
2025
Q2
$3.61M Buy
16,504
+374
+2% +$60.4K 1.08% 18
2025
Q1
$2.26M Buy
16,130
+231
+1% +$37.6K 0.83% 38
2024
Q4
$2.65M Sell
15,899
-667
-4% -$118K 0.95% 27
2024
Q3
$2.82M Buy
16,566
+1,319
+9% +$191K 1.04% 22
2024
Q2
$2.15M Buy
15,247
+385
+3% +$47.8K 0.89% 33
2024
Q1
$1.87M Buy
14,862
+2,009
+16% +$230K 0.82% 46
2023
Q4
$1.36M Buy
12,853
+901
+8% +$98.3K 0.64% 64
2023
Q3
$1.27M Buy
+11,952
New +$1.38M 0.69% 61
2022
Q2
Sell
-210
Closed -$17K 243
2022
Q1
$17K Hold
210
0.01% 187
2021
Q4
$18K Hold
210
0.01% 173
2021
Q3
$18K Hold
210
0.01% 167
2021
Q2
$16K Buy
+210
New +$16.4K 0.01% 166

Other funds holding ORCL

Alaethes Wealth's ORCL Position: Q2 2026 in Review

Alaethes Wealth sold out of Oracle (ORCL) in Q2 2026, closing a stake of 13,953 shares — an estimated $2.05M sold.

Alaethes Wealth first reported a position in ORCL in Q2 2021 and held it in 15 quarters. The position peaked at $3.84M in Q3 2025. 3,519 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Alaethes Wealth reported no remaining Oracle position as of Q2 2026 after selling out during the quarter.
  • Alaethes Wealth sold 13,953 Oracle shares in Q2 2026, an estimated $2.05M.
  • Alaethes Wealth first reported a position in Oracle in Q2 2021 and held it in 15 quarters.
  • Alaethes Wealth's Oracle position peaked at $3.84M in Q3 2025.
  • 3,519 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Alaethes Wealth's 13F filing for Q2 2026, filed 14 Aug 2026.